Central Nervous System (CNS) Market Research - Size, Trends, and Forecast Market Analysis

CNS Market Research Analysis

The size of the global central nervous system (CNS) therapeutics market will increase USD 18.64 billion between 2017-2022, accelerating at a CAGR of 4% during the forecast period. This growth in market size will be attributed to the rapidly growing geriatric population which is leading to an increase in the number of neurological disease cases. Additionally, there is an increasing prevalence of mental illnesses which is also contributing to the market's growth. In 2017, it was recorded that approximately 20% of the US population suffered from mental disorders.

Several emerging trends are expected to gain traction over the next few years and positively impact the global CNS market. These top trends include the increased adoption of new-generation drugs, advances in technology in treating mental disorders, and the increasing number of CNS awareness programs. The number of awareness programs about CNS diseases continues to rise, for example, March 30th is World Bipolar Day which brings awareness about bipolar disorder and helps to eliminate social stigma. Other insights provided within Technavio’s CNS market reports include:

CNS Market Insights

  • The increasing prevalence of mental illness will be one of the major factors driving CNS market growth. According to the Centers for Disease Control and Prevention (CDC), most of these disorders coexist with other diseases such as diabetes, cardiovascular disease, and obesity.
  • One of the recent trends gaining traction in the CNS disorders therapeutics market is the increasing focus on regenerative therapies for CNS disorders. These therapies help in the healing process by replacement or regeneration of human cells, tissues or organs, and various regenerative therapies, including stem cells, growth factors, and the use of a matrix such as fibrin, collagen, and hyaluronic acid.
  • One of the factors contributing to the growth of the CNS disorders therapeutics market value will be the allotment of special regulatory designations for CNS disorders. The designations assigned to drugs by the US Food and Drug Administration and European Medicines Agency help in the faster entry of these drugs into the market for the treatment of serious conditions.

CNS Market Share and Segmentation

Within our central nervous system industry research, we provide deep insights into the market landscape, its segments, and their market share. Our central nervous system market segmentation research offerings include:

  • Brain Disorder Market
    • Dementia market
      • Alzheimer’s disease market
      • Vascular dementia (VaD) market
      • Lewy body dementia (LBD) market
    • Brain cancer market
      • Primary brain tumors market
      • Secondary or metastatic brain cancer market
    • Seizure disorders market
      • Focal seizures market
      • Generalized seizures market
    • Movement disorders market
    • Stroke market
      • Ischemic market
      • Hemorrhagic market
  • Spinal Disorder Market
    • Lordosis market
    • Kyphosis market
      • Postural kyphosis market
      • Scheuermann's kyphosis (Scheuermann's disease) market
      • Congenital kyphosis market
    • Scoliosis market

In addition to the above-mentioned markets, our reports within the CNS industry also provide critical insights on several markets for treatments and procedures such as the deep brain stimulation devices market, bipolar disorder therapeutics market, post-traumatic stress disorder (PTSD) therapeutics market, and migraine drugs market. Further, Technavio’s research reports offer a comprehensive understanding of the market space along with the factors that are impacting the growth patterns in the coming years.

Our market research reports within the central nervous system industry offer a detailed market analysis based on the latest trends and drivers that are anticipated to influence the growth patterns over the coming years. Our market research covers several critical insights within the CNS industry such as:

  • CNS market share
  • CNS market size
  • CNS market growth
  • CNS market forecast
  • CNS market trends
  • CNS industry statistics

CNS Clinical Trials

Our industry analysts critically observe the development taking place in clinical trials CNS and neurological disorders market across the globe. Our pipeline reports cover the entire development phase of the drug ending with the registration of new drugs. For further insights, our CNS & neurological disorders clinical submissions are classified as biosimilars or new molecular entity.

CNS Market Research – Report Catalog

  • Ankylosing Spondylitis Market
  • Protein Therapeutics Market
  • Autoimmune Drugs Market
  • Alzheimer Disease Therapies Market
  • Back Pain Therapies Market
  • Brain Injury Treatment Market

CNS Market Research – Pipeline Analysis Reports

  • Brain injury - A Pipeline Analysis Report
  • Breakthrough cancer Pain - A Pipeline Analysis Report
  • Carotid Artery Disease - A Pipeline Analysis Report
  • Cerebral Arterial Diseases - A Pipeline Analysis Report

For More Insights on Central Nervous System (CNS) Market
Research - Size, Trends, and Forecast Market Analysis

17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>